Hexcel's revenue rose 8.8% while net income rose 87.4%
Hexcel (HXL) filed its quarterly report (10-Q) for July 1 to September 30, 2026 on October 21. Compared with the same period a year earlier, revenue rose 8.8% and net income rose 87.4%.
Articles from US 10-Q and 10-K filings. Pick a sector or search.
Hexcel (HXL) filed its quarterly report (10-Q) for July 1 to September 30, 2026 on October 21. Compared with the same period a year earlier, revenue rose 8.8% and net income rose 87.4%.





Nurix Therapeutics (NRIX) filed its quarterly report (10-Q) for fiscal Q3 2026 on October 13. Net income went from −$86.4m in the same period a year earlier to $549.8m.

Tilray Brands (TLRY) filed its quarterly report (10-Q) for fiscal Q1 2027 on October 8. The net loss widened by $42.8m, from $0.3m in the same period a year earlier to $43.1m. The company remained loss-making.

Tempus AI (TEM) reported second-quarter 2026 revenue of $382.5m, up 22%, and swung from a $42.8m net loss a year earlier to **net income of $5.6m**. Reading down the income statement in the 10-Q filed on July 24 shows where that profit came from: the operating result is a loss of $75.9m, and the line beneath it, other income net, is $102.8m.

Hims & Hers Health (HIMS) reported second-quarter 2026 revenue of $753.2m, up 38%, and swung from a $26.7m operating profit a year earlier to a $97.2m operating loss. The balance sheet in the 10-Q filed on August 10 carries a line that was not there at the end of last year: Receivables, net of $375.3m. At December 31 the same line was $32.1m.

UnitedHealth Group (UNH) reported revenue of $112,032m for the second quarter of 2026, almost unchanged from a year earlier, and net earnings of $5,484m, up 61%. The medical-costs-payable note of the 10-Q filed on August 10 shows where the rebound came from: a release of reserves set aside for last year's claims.

Eli Lilly (LLY) reported revenue of $22,974m for the second quarter of 2026, up 48%, and net income of $7,095m. One line in the revenue note of the 10-Q filed on August 5 says that 3% of U.S. revenue came from revising rebate estimates on earlier shipments — up from 1% a year earlier.
Mostly during earnings season — an article for each covered company when its 10-Q or 10-K is filed, plus material 8-K filings when relevant.
Yes. Send a request through Messages after logging in and we will consider it for the next earnings season. License customers may nominate priority tickers.
The company's articles and a table of key metrics that accumulates quarter by quarter, so the same figure can be compared over time.